An investigation of the molecular mechanisms engaged before and after the development of Alzheimer disease neuropathology in Down syndrome: a proteomics approach
Open Access
- 1 November 2014
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 76, 89-95
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AG-05119)
- National Institute of Child Health and Human Development (HD-064993)
- NIH (P50 AG16573)
This publication has 66 references indexed in Scilit:
- A gel-based proteomic method reveals several protein pathway abnormalities in fetal Down syndrome brainJournal of Proteomics, 2011
- Multifunctional roles of enolase in Alzheimer’s disease brain: beyond altered glucose metabolismJournal of Neurochemistry, 2009
- Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of ADBrain Research, 2009
- Redox proteomic identification of 4-Hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's diseaseNeurobiology of Disease, 2008
- Beta-Amyloid, Oxidative Stress and Down SyndromeCurrent Alzheimer Research, 2006
- Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's diseaseNeurobiology of Disease, 2006
- Down syndrome and beta-amyloid depositionCurrent Opinion in Neurology, 2004
- Genetic and host factors for dementia in Down's syndromeThe British Journal of Psychiatry, 2002
- Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptideTrends in Molecular Medicine, 2001
- PRECOCIOUS AGING AND DEMENTIA IN PATIENTS WITH DOWNS-SYNDROME1978